Cession Oncology

Private

United StatesHealthcare & Life Scienceshttp://www.cessiononcology.com/

Company Overview

Cession Oncology is a biotechnology company developing targeted RNA therapeutics for pancreatic cancer.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

nanoparticle deliveryRNA therapeuticspancreatic cancerdrug delivery platformbiotech startupinvestigational new drugINDtumor microenvironmentprecision medicinedrug discoverytargeted therapypreclinical biotechnanomedicineRNA medicineoncology pipeline

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Cession Oncology Comparables

Compare Cession Oncology with similar companies based on industry and business-model similarity.

Cession Oncology comparables — related companies by embedding similarity
Company	Similarity	Market Cap
Onselex Pharmaceuticals	86%
Palto Therapeutics	84%
PushCART Therapeutics, Inc.	74%

View all Comparables

Cession Oncology Funding Rounds

Historical fundraising activity

View Full Funding History

Access detailed round history, amounts raised, valuations, and investors.

Key People

Founding team and executive leadership

David Seaburg

Co-Founder Chief Operating Officer, Member Board of Directors

Founding Team

Cession Oncology Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Cession Oncology Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Cession Oncology's valuation, stock price, and market status.

Firmographic Details

HeadquartersUnited States

Employee Range2

Year FoundedN/A

Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?